Structural analysis of tumor-related single amino acid mutations in human MxA protein.

Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers. Cancer Res Treat (2016) 0.75

Clustal W and Clustal X version 2.0. Bioinformatics (2007) 126.47

Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46

Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72

Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55

The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88

The mutational landscape of lethal castration-resistant prostate cancer. Nature (2012) 11.82

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69

The guanine nucleotide-binding switch in three dimensions. Science (2001) 9.34

SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res (2014) 8.86

The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol (2004) 8.58

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23

Recurrent R-spondin fusions in colon cancer. Nature (2012) 5.10

Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61

Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol (2005) 3.75

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med (2014) 3.62

Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity (2011) 2.33

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist (2001) 2.22

cDNA cloning and assignment to chromosome 21 of IFI-78K gene, the human equivalent of murine Mx gene. Somat Cell Mol Genet (1988) 2.13

Crystal structure of nucleotide-free dynamin. Nature (2011) 2.13

Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature (2010) 2.01

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A (2013) 2.00

The crystal structure of dynamin. Nature (2011) 1.87

The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect (2007) 1.76

Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell (2013) 1.72

Genetics of follicular lymphoma transformation. Cell Rep (2014) 1.70

An intramolecular signaling element that modulates dynamin function in vitro and in vivo. Mol Biol Cell (2009) 1.68

RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet (2014) 1.57

Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res (2014) 1.47

Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe (2012) 1.29

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res (2014) 1.24

Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia (2009) 1.14

Emergence and decay of the human Mx homolog in cancer patients during and after interferon-alpha therapy. J Biol Response Mod (1990) 1.14

Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop. J Biol Chem (2011) 1.11

Interferon-lambda as a potential therapeutic agent in cancer treatment. J Interferon Cytokine Res (2010) 1.10

Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04

Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. J Virol (2014) 0.99

Cancer immunotherapy in clinical practice -- the past, present, and future. Chin J Cancer (2014) 0.98

Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem (2009) 0.97

Transient dimerization of human MxA promotes GTP hydrolysis, resulting in a mechanical power stroke. Structure (2014) 0.93

Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity. J Biol Chem (2015) 0.88

Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis. Prostate (2014) 0.84

Cancer research in the era of next-generation sequencing and big data calls for intelligent modeling. Chin J Cancer (2015) 0.77

Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy? J Interferon Cytokine Res (1996) 0.77